Bunge

Archer-Daniels-Midland

Grain Industry Looks to 2026 for a More Stable Year After Turbulent 2021

Bunge Global Exceeds Expectations with Adjusted Earnings, Viterra Synergies, and Integration Progress.

邦吉

Bunge's 15min chart triggers Bollinger Bands Narrowing, KDJ Death Cross alert.

Jpmorgan Chase

JPMorgan Maintains Overweight on Bunge, Raises PT to $130 from $117

UBS Group

UBS Raises Bunge's PT to $145 from $108, Maintains Buy Rating

Catalyst<ul> <li>Most analysts rate BG Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li> <li>Extra-large fund flows show negative outflow trends, indicating reduced confidence from large investors.</li></ul>

Key Factors

Bunge Global reported Q4 2025 results with sales rising to $23.76 bln from $13.54 bln YoY but net income fell to $95 mln from $602 mln.Bunge exceeded analyst expectations on adjusted earnings and highlighted early synergy gains from its Viterra combination.JPMorgan maintained an Overweight rating on Bunge and raised its price target to $130 from $117.UBS raised Bunge's price target to $145 from $108 and maintained a Buy rating.Morgan Stanley maintained an Overweight rating on Bunge with a price target raised to $130.

Recent Updates

BG News